Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;6(11):e26675.
doi: 10.1371/journal.pone.0026675. Epub 2011 Nov 1.

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis

Affiliations

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis

Ana Luisa de Jesus Lopes Ribeiro et al. PLoS One. 2011.

Abstract

Tuberculosis is still a leading cause of death worldwide. The selection and spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem. Recently, two different classes of chemical series, the benzothiazinones (BTZ) and the dinitrobenzamide (DNB) derivatives have been found to be highly active against M. tuberculosis, including XDR-TB strains. The target of BTZs is DprE1 protein which works in concert with DprE2 to form the heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase, involved in Decaprenyl-Phospho-Arabinose (DPA) biosynthesis. Interestingly, it has been shown that the DNBs block the same pathway thus suggesting that both drugs could share the same target. Moreover, in Mycobacterium smegmatis the overexpression of the NfnB nitroreductase led to the inactivation of the BTZs by reduction of a critical nitro-group to an amino-group. In this work several spontaneous M. smegmatis mutants resistant to DNBs were isolated. Sixteen mutants, showing high levels of DNB resistance, exhibited a mutation in the Cys394 of DprE1. Using fluorescence titration and mass spectrometry it has been possible to monitor the binding between DprE1 and DNBs, achieving direct evidence that MSMEG_6382 is the cellular target of DNBs in mycobacteria. Additionally, M. smegmatis mutants having low levels of resistance to DNBs harbor various mutations in MSMEG_6503 gene encoding the transcriptional repressor of the nitroreductase NfnB. By LC/MS analysis it has been demonstrated that NfnB is responsible for DNB inactivation. Taken together, our data demonstrate that both DNB and BTZ drugs share common resistance mechanisms in M. smegmatis.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Titration of DprE1 with DNBs.
Fluorescence spectra of DprE1 at increasing concentrations of DNB1 (A) and DNB3 (B); the fluorescence intensities are reported in arbitrary units. The dashed lines represent the fluorescence spectra of a blank sample containing 256 µM of ligand. All measurements were performed at 25°C, as reported in “Materials and Methods” section. (C) Titration curves of DprE1 with DNB1 (•), and with DNB3 (○). Lines are the fit of the data to equation 1.
Figure 2
Figure 2. LC/MS2 analysis of DNB transformed by NfnB.
DNB1 was incubated with M. smegmatis NfnB in presence of NADH and the mixture was analyzed by LC/MS2 A. DNB1; B. hydroxyl-amine form of DNB1 that is detected after a 30 min incubation at 37°C.

Similar articles

Cited by

References

    1. Zumla A, Mwaba P, Huggett J, Kapata N, Chanda D, et al. Reflections on the white plague. Lancet Infect Dis. 2009;9:197–202. - PubMed
    1. Jain A, Mondal R. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol. 2008;53:145–150. - PubMed
    1. Zignol M, Hosseini MS, Wright A, Weezenbak CL, Nunn P, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194:479–485. - PubMed
    1. Riccardi G, Pasca MR, Buroni S. Mycobacterium tuberculosis: drug resistance and future perspectives. Future Microbiol. 2009;4:597–614. - PubMed
    1. Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest. 2009;136:420–425. - PubMed

Publication types

MeSH terms